Brandt B - Search Results

1

The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy.

Mikesch JH, Schier K, Roetger A, Simon R, Buerger H, Brandt B. Mikesch JH, et al. Among authors: brandt b. Cell Oncol. 2006;28(5-6):223-32. doi: 10.1155/2006/814816. Cell Oncol. 2006. PMID: 17167176 Free PMC article. Review.

2

Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies.

Mikesch JH, Buerger H, Simon R, Brandt B. Mikesch JH, et al. Among authors: brandt b. Biochim Biophys Acta. 2006 Aug;1766(1):42-52. doi: 10.1016/j.bbcan.2006.04.001. Epub 2006 May 9. Biochim Biophys Acta. 2006. PMID: 16784816 Review.

3

Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.

Brandt B, Mikesch JH, Simon R, Rötger A, Kemming D, Schier K, Sauter G, Bürger H. Brandt B, et al. Biochem Biophys Res Commun. 2005 Apr 1;329(1):318-23. doi: 10.1016/j.bbrc.2005.01.138. Biochem Biophys Res Commun. 2005. PMID: 15721309

4

Egfr amplification specific gene expression in phyllodes tumours of the breast.

Agelopoulos K, Kersting C, Korsching E, Schmidt H, Kuijper A, August C, Wülfing P, Tio J, Boecker W, van Diest PJ, Brandt B, Buerger H. Agelopoulos K, et al. Among authors: brandt b. Cell Oncol. 2007;29(6):443-51. doi: 10.1155/2007/754712. Cell Oncol. 2007. PMID: 18032821 Free PMC article.

5

Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential.

Brandt B, Roetger A, Bidart JM, Packeisen J, Schier K, Mikesch JH, Kemming D, Boecker W, Yu D, Buerger H. Brandt B, et al. Cancer Res. 2002 Feb 15;62(4):1020-4. Cancer Res. 2002. PMID: 11861376

6

Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma.

Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H. Fillies T, et al. Among authors: brandt b. Oncol Rep. 2007 Sep;18(3):639-43. Oncol Rep. 2007. PMID: 17671713

7

Allelic imbalances of the egfr gene as key events in breast cancer progression--the concept of committed progenitor cells.

Agelopoulos K, Buerger H, Brandt B. Agelopoulos K, et al. Among authors: brandt b. Curr Cancer Drug Targets. 2008 Aug;8(5):431-45. doi: 10.2174/156800908785133213. Curr Cancer Drug Targets. 2008. PMID: 18690849 Review.

8

Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas.

Fillies T, Woltering M, Brandt B, Van Diest JP, Werkmeister R, Joos U, Buerger H. Fillies T, et al. Among authors: brandt b. Oncol Rep. 2007 Feb;17(2):355-9. Oncol Rep. 2007. PMID: 17203174

9

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H. Korsching E, et al. Among authors: brandt b. Lab Invest. 2002 Nov;82(11):1525-33. doi: 10.1097/01.lab.0000038508.86221.b3. Lab Invest. 2002. PMID: 12429812 Free article.

10

Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene.

Brandt B, Hermann S, Straif K, Tidow N, Buerger H, Chang-Claude J. Brandt B, et al. Cancer Res. 2004 Jan 1;64(1):7-12. doi: 10.1158/0008-5472.can-03-2623. Cancer Res. 2004. PMID: 14729599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

651 results

Search Page